ReleaseWire Connect

Fact.MR has announced the addition of the “ Pigmentosa Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Fact.MR has announced the addition of the “Veterinary Progesterone Testing Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may also vary person to person. The exhaustive study of changes in gene expression and mutation patterns in different cancer type is one of the most studied topic for developing novel cure for cancer. Cancer RNA expression plays an important role in the studying mutation patterns and if understood wholly for particular person it may help in speedy recovery and cure. In recent days the gene therapy for cancer treatment is mainly driven by the cancer RNA expression and DNA expression. Cancer RNA expression plays an important role in the PCR sequencing enabling enhanced understanding of different mutations in cancerous cells.

Fact.MR has announced the addition of the “Gas Exchange Monitor Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Fact.MR has announced the addition of the “Treatment-Resistance Depression Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2018 to 2028"report to their offering.

Avascular necrosis is a condition in which bone tissue dies due to reduced blood flow to bones. Avascular necrosis also is known as osteonecrosis, bone necrosis, aseptic necrosis, and ischemic bone necrosis. Avascular necrosis commonly occurs in body sites such as hip, shoulder, ankle, and knees. Avascular necrosis is basically two type's traumatic avascular necrosis and non-traumatic avascular necrosis. Avascular necrosis can be the result as reduction of blood supply due to fracture and dislocation of bone, excessive use of chronic corticosteroids and alcohol. Other conditions associated with non-traumatic avascular necrosis are sickle cell disease, metabolic bone disorders such as Gaucher disease etc. Therapeutic treatment and surgical treatment are available to treat avascular necrosis. Surgical treatment procedures such as bone grafting, osteotomy, total joint replacement, core decompression, vascularized bone graft placement are performed to treat avascular necrosis. Therapeutic treatment such as nonsteroidal anti-inflammatory drugs (NSAIDS), osteoporosis drugs, cholesterol-lowing drugs, blood thinners are prescribed to treat avascular necrosis.

Nicotine is a chemical containing nitrogen which is generally derived from tobacco plant. Nicotine is a natural alkaloid and is a major component of cigarettes. Nicotine constitutes of approximately 0.6 to 3.0% dry weight of tobacco. Use of tobacco causes serious diseases. Nicotine act as the main ingredient in products containing tobacco and use of tobacco in long run makes individual addicted to tobacco. Nicotine replacement therapy is a treatment given to people for cessation of cigarette. It aims to minimize the consumption of tobacco and makes the individual get rid of psychomotor withdrawal and physiological symptoms. Nicotine replacement therapy uses products that supply nicotine at its low dose unlike cigarette that contains high amount of nicotine which as a result causes lung cancer, asthma and other chronic diseases.

Skeletal dysplasia is a heterogeneous group of more than 450 disorders. Skeletal dysplasia encompasses a board number of development bone and cartilage disorders. There is very wide spectrum and any part of the skeleton can be affected including abnormalities of bone size, shape, density, and short stature. Skeletal dysplasia caused by disturbance of bone growth during the early stage of fetal development. Some skeletal dysplasia can be detected before birth and others are identified after birth. Orthopedic, neurologic, pulmonary, visual, auditory, cardiac, renal complications are also associated with skeletal dysplasia.

Pharmacogenomic (PGx) testing is study of the effect of individual genetic make-up on the therapeutic effect of the medication. The individual response to the medication is determined by the various factor such as weight, age, diet, habits, and genetic factors, etc. The genetic make-up of the individual majorly decides the metabolism rate of the medication along with other factors. Depending on the variation in person to person gene make-up, metabolism of the medication varies significantly. One drug that works efficiently may not work for the other person due to variation in the time for metabolism. For example, prodrugs administered are required to be converted into the active form for the therapeutic effect whereas if the metabolism rate is too slow then amount of the prodrug converted to active form may be very less hampering the desired bioavailability of actual active drug which in turn may not work. Whereas, if the metabolism is too fast for the prodrug then too much of active drug can result in the hyperactivity.

Pleural membrane is a moist, thin, slippery two layered membrane. The parietal, or outer, pleura lines present inside the diaphragm and rib cage whereas the visceral or pulmonary, inner layer cover the lungs. Intrapleural space is present between these two layers, which typically consists of fluid secreted by these membranes. Pleural catheters) are considered to be one of the most important tools for managing recurring pleural effusions. MPE (Malignant pleural effusion) is one often occurring cause of life deterioration among patients suffering with advanced cancer. The management available for these effusions include the placement of tunneled pleural catheters, and also chemical pleurodesis with any sclerosing agent like talc powder or doxycycline, or surgery. According to various researches conducted in the United States, approximately 150,000 people are affected with malignant pleural effusion every year. It is also considered to occur in around 15% of patients diagnosed with advanced malignancies, majorly, breast cancer, lung cancer, ovarian cancer, and lymphoma. Ovarian cancer is considered to account for around 50% of the malignant pleural effusion cases in the United States. A pleural catheter is used at times when these malignant pleural effusion becomes symptomatic and recurs post thoracentesis, majorly in the patient with trapped lung or with low to moderate life expectancy, or who underwent unsuccessful pleurodesis.